These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The fate of anergic T cells in vivo.
    Author: Migita K, Ochi A.
    Journal: J Immunol; 1993 Feb 01; 150(3):763-70. PubMed ID: 8423339.
    Abstract:
    The kinetics of Staphylococcal enterotoxin B-(SEB) induced peripheral tolerance has been investigated. Ten days after SEB injection, thymectomized BALB/cByJ mice showed suppressed spleen cell proliferative responses to SEB. After 2 mo the SEB-specific response was partly recovered. Four months later the response of spleen cells of SEB-primed mice was comparable to those of control mice. The proportion of CD4+, V beta 8+ T cells was diminished in the tolerized mice and was not restored even after the response was recovered. Purified CD4+, V beta 8+ T cells from SEB-primed mice after 4 mo responded similarly to SEB as control CD4+, V beta 8+ T cells. These expressed a similar profile of surface markers compared with that of unprimed control cells, except a homing receptor was slightly lower. An experiment that addressed the possibility that non-anergic T cells expand over time and are in fact responsible for the recovery of the proliferative response showed that such events unlikely occur in vivo. Therefore, the data indicate that T cell anergy is reversible in vivo. It is also suggested that the challenge with superantigen results in neither clonal expansion nor specific CD4+, V beta 8+ T cell memory.
    [Abstract] [Full Text] [Related] [New Search]